| Arbab Iqbal, | |
|
Geisinger Medical Ctr, 100 North Academy Avenue, Danville, PA 17822-0001 | |
| (570) 271-6211 | |
| Not Available |
| Full Name | Arbab Iqbal |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 13 Years |
| Location | Geisinger Medical Ctr, Danville, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063711240 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 282210 (New York) | Primary |
| 2085N0700X | Radiology - Neuroradiology | 282210 (New York) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Rochester General Hospital | Rochester, NY | Hospital |
| Unity Hospital | Rochester, NY | Hospital |
| Newark-wayne Community Hospital | Newark, NY | Hospital |
| United Memorial Medical Center | Batavia, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rochester General Hospital | 0244149474 | 891 |
| United Memorial Medical Center | 0547259376 | 180 |
| Western New York Medical Practice Pc | 3870767791 | 423 |
| The Unity Hospital Of Rochester | 9436060969 | 517 |
News Archive
Leading diabetes researchers believe smartphone craze Pokémon Go could be an "innovative solution" to rising obesity levels and chronic disease.
Octapharma AG recently submitted its Biological License Application for octagam(R) 10% (human normal intravenous immunoglobulin, liquid) to the U.S. Food and Drug Administration (FDA) with the goal of expanding the biopharmaceutical company's U.S. immune globulin therapy portfolio by early 2010. The application was submitted for the treatment of Idiopathic Thrombocytopenic Purpura (ITP), a blood-clotting disorder that can result in excessive bruising and bleeding.
IMBiotechnologies Ltd., a privately held biotechnology company focused on developing medical device products for use in the area of embolotherapy, today announced that it has received regulatory concurrence from the United States Food and Drug Administration to market its lead product, Occlusin 500 Artificial Embolization Device in the U.S. for the treatment of unresectable/inoperable hypervascularized tumours.
MR Solutions has installed Hawaii's first preclinical cryogen-free MRI imaging system to help researchers improve the rate of kidney disease detection through research.
› Verified 9 days ago
| Entity Name | Borg & Ide Imaging Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194714402 PECOS PAC ID: 9931012960 Enrollment ID: O20031106000514 |
News Archive
Leading diabetes researchers believe smartphone craze Pokémon Go could be an "innovative solution" to rising obesity levels and chronic disease.
Octapharma AG recently submitted its Biological License Application for octagam(R) 10% (human normal intravenous immunoglobulin, liquid) to the U.S. Food and Drug Administration (FDA) with the goal of expanding the biopharmaceutical company's U.S. immune globulin therapy portfolio by early 2010. The application was submitted for the treatment of Idiopathic Thrombocytopenic Purpura (ITP), a blood-clotting disorder that can result in excessive bruising and bleeding.
IMBiotechnologies Ltd., a privately held biotechnology company focused on developing medical device products for use in the area of embolotherapy, today announced that it has received regulatory concurrence from the United States Food and Drug Administration to market its lead product, Occlusin 500 Artificial Embolization Device in the U.S. for the treatment of unresectable/inoperable hypervascularized tumours.
MR Solutions has installed Hawaii's first preclinical cryogen-free MRI imaging system to help researchers improve the rate of kidney disease detection through research.
› Verified 9 days ago
| Entity Name | Rochester General Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356412712 PECOS PAC ID: 0244149474 Enrollment ID: O20031121000644 |
News Archive
Leading diabetes researchers believe smartphone craze Pokémon Go could be an "innovative solution" to rising obesity levels and chronic disease.
Octapharma AG recently submitted its Biological License Application for octagam(R) 10% (human normal intravenous immunoglobulin, liquid) to the U.S. Food and Drug Administration (FDA) with the goal of expanding the biopharmaceutical company's U.S. immune globulin therapy portfolio by early 2010. The application was submitted for the treatment of Idiopathic Thrombocytopenic Purpura (ITP), a blood-clotting disorder that can result in excessive bruising and bleeding.
IMBiotechnologies Ltd., a privately held biotechnology company focused on developing medical device products for use in the area of embolotherapy, today announced that it has received regulatory concurrence from the United States Food and Drug Administration to market its lead product, Occlusin 500 Artificial Embolization Device in the U.S. for the treatment of unresectable/inoperable hypervascularized tumours.
MR Solutions has installed Hawaii's first preclinical cryogen-free MRI imaging system to help researchers improve the rate of kidney disease detection through research.
› Verified 9 days ago
| Entity Name | The Unity Hospital Of Rochester |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760421713 PECOS PAC ID: 9436060969 Enrollment ID: O20031230000038 |
News Archive
Leading diabetes researchers believe smartphone craze Pokémon Go could be an "innovative solution" to rising obesity levels and chronic disease.
Octapharma AG recently submitted its Biological License Application for octagam(R) 10% (human normal intravenous immunoglobulin, liquid) to the U.S. Food and Drug Administration (FDA) with the goal of expanding the biopharmaceutical company's U.S. immune globulin therapy portfolio by early 2010. The application was submitted for the treatment of Idiopathic Thrombocytopenic Purpura (ITP), a blood-clotting disorder that can result in excessive bruising and bleeding.
IMBiotechnologies Ltd., a privately held biotechnology company focused on developing medical device products for use in the area of embolotherapy, today announced that it has received regulatory concurrence from the United States Food and Drug Administration to market its lead product, Occlusin 500 Artificial Embolization Device in the U.S. for the treatment of unresectable/inoperable hypervascularized tumours.
MR Solutions has installed Hawaii's first preclinical cryogen-free MRI imaging system to help researchers improve the rate of kidney disease detection through research.
› Verified 9 days ago
| Entity Name | United Memorial Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902800352 PECOS PAC ID: 0547259376 Enrollment ID: O20040507000847 |
News Archive
Leading diabetes researchers believe smartphone craze Pokémon Go could be an "innovative solution" to rising obesity levels and chronic disease.
Octapharma AG recently submitted its Biological License Application for octagam(R) 10% (human normal intravenous immunoglobulin, liquid) to the U.S. Food and Drug Administration (FDA) with the goal of expanding the biopharmaceutical company's U.S. immune globulin therapy portfolio by early 2010. The application was submitted for the treatment of Idiopathic Thrombocytopenic Purpura (ITP), a blood-clotting disorder that can result in excessive bruising and bleeding.
IMBiotechnologies Ltd., a privately held biotechnology company focused on developing medical device products for use in the area of embolotherapy, today announced that it has received regulatory concurrence from the United States Food and Drug Administration to market its lead product, Occlusin 500 Artificial Embolization Device in the U.S. for the treatment of unresectable/inoperable hypervascularized tumours.
MR Solutions has installed Hawaii's first preclinical cryogen-free MRI imaging system to help researchers improve the rate of kidney disease detection through research.
› Verified 9 days ago
| Entity Name | Western New York Medical Practice Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063790608 PECOS PAC ID: 3870767791 Enrollment ID: O20111110000598 |
News Archive
Leading diabetes researchers believe smartphone craze Pokémon Go could be an "innovative solution" to rising obesity levels and chronic disease.
Octapharma AG recently submitted its Biological License Application for octagam(R) 10% (human normal intravenous immunoglobulin, liquid) to the U.S. Food and Drug Administration (FDA) with the goal of expanding the biopharmaceutical company's U.S. immune globulin therapy portfolio by early 2010. The application was submitted for the treatment of Idiopathic Thrombocytopenic Purpura (ITP), a blood-clotting disorder that can result in excessive bruising and bleeding.
IMBiotechnologies Ltd., a privately held biotechnology company focused on developing medical device products for use in the area of embolotherapy, today announced that it has received regulatory concurrence from the United States Food and Drug Administration to market its lead product, Occlusin 500 Artificial Embolization Device in the U.S. for the treatment of unresectable/inoperable hypervascularized tumours.
MR Solutions has installed Hawaii's first preclinical cryogen-free MRI imaging system to help researchers improve the rate of kidney disease detection through research.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Arbab Iqbal, 60 Presidential Plz, Syracuse, NY 13202-2292 Ph: (585) 278-2699 | Arbab Iqbal, Geisinger Medical Ctr, 100 North Academy Avenue, Danville, PA 17822-0001 Ph: (570) 271-6211 |
News Archive
Leading diabetes researchers believe smartphone craze Pokémon Go could be an "innovative solution" to rising obesity levels and chronic disease.
Octapharma AG recently submitted its Biological License Application for octagam(R) 10% (human normal intravenous immunoglobulin, liquid) to the U.S. Food and Drug Administration (FDA) with the goal of expanding the biopharmaceutical company's U.S. immune globulin therapy portfolio by early 2010. The application was submitted for the treatment of Idiopathic Thrombocytopenic Purpura (ITP), a blood-clotting disorder that can result in excessive bruising and bleeding.
IMBiotechnologies Ltd., a privately held biotechnology company focused on developing medical device products for use in the area of embolotherapy, today announced that it has received regulatory concurrence from the United States Food and Drug Administration to market its lead product, Occlusin 500 Artificial Embolization Device in the U.S. for the treatment of unresectable/inoperable hypervascularized tumours.
MR Solutions has installed Hawaii's first preclinical cryogen-free MRI imaging system to help researchers improve the rate of kidney disease detection through research.
› Verified 9 days ago
Dr. Tana M. Shaffer, D.O. Radiology Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6301 | |
Leslie C. Scott, D.O. Radiology Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-560-1628 Fax: 570-560-1628 | |
Dr. Mary L. Strickland, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6301 | |
Clara Jean Chudow, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6301 Fax: 570-271-5976 | |
Dr. Faruq Mahmud, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6301 | |
Dr. Marta J. Carleton, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6301 |